Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Simultaneous detection of <i>HER2/neu</i> gene amplification and protein overexpression in paraffin‐embedded breast cancer

24 Feb 2005

Abstract excerpt

The determination of HER2/neu status in breast carcinomas has become essential for the selection of breast cancer patients for Herceptin therapy. Herceptin treatment is used in patients with metastatic breast carcinoma with HER2/neu protein overexpression detected by immunohistochemistry (IHC) or gene amplification analysed by fluorescence in situ hybridization (FISH). A multiparametric fluorescent approach based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Biosensing Techniques and Applications
Share to HER2/EGFR in Cancer Research
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15732132
DOI: 10.1002/path.1742

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Simultaneous detection of <i>HER2/neu</i> gene amplification and protein overexpression in paraffin‐embedded breast cancerPMID 15732132Read ↗

HER-2/<i>neu</i> Analysis in Archival Tissue Samples of Human Breast Cancer: Comparison of Immunohistochemistry and Fluorescence In Situ HybridizationSemantic proximity Read ↗

Evaluation of HER-2/neu Gene Amplification and Overexpression: Comparison of Frequently Used Assay Methods in a Molecularly Characterized Cohort of Breast Cancer SpecimensSemantic proximity Read ↗

Validation of Dual-Color Dual In Situ Hybridization for HER2/neu Gene in Breast CancerSemantic proximity Read ↗

Real‐time reverse transcription‐PCR and fluorescence <i>in‐situ</i> hybridization are complementary to understand the mechanisms involved in HER‐2/<i>neu</i> overexpression in human breast carcinomasSemantic proximity Read ↗

Activation of multiple cancer-associated genes at the <i>ERBB2</i> amplicon in breast cancerSemantic proximity Read ↗

Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinomaSemantic proximity Read ↗

<i>HER2</i> Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical TrialsSemantic proximity Read ↗

Simultaneous fluorescence immunophenotyping and Her-2/neu genotyping (FICTION) in breast carcinoma candidates to target therapy.Semantic proximity Read ↗

Clinical Laboratory Assays for HER-2/ <i>neu</i> Amplification and OverexpressionSemantic proximity Read ↗

Aberrations of <i>ERBB2</i> and <i>TOP2A</i> genes in breast cancerSemantic proximity Read ↗

<i>HER2</i>Amplification in Gastroesophageal AdenocarcinomaSemantic proximity Read ↗

Determination of <i>HER2</i> amplification in primary breast cancer using dual‐colour chromogenic <i>in situ</i> hybridization is comparable to fluorescence <i>in situ</i> hybridization: a European multicentre study involving 168 specimensSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.